Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 24.44 mg
Medis Pharma Pty Ltd
Gum, chewing
Excipient Ingredients: menthol; sodium carbonate; butylated hydroxytoluene; quinoline yellow aluminium lake; sodium bicarbonate; Carnauba Wax; purified talc; acesulfame potassium; sorbitol; Flavour; Colour; calcium carbonate; isobutylene/isoprene copolymer; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; synthetic terpene resin; microcrystalline wax; hydrogenated vegetable oil; mono- and di- glycerides
Buccal
120, 30
Not scheduled. Not considered by committee
Treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. In smokers currently unable or not ready to stop smoking abruptly, the gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.
Visual Identification: Yellowish square, biconvex gum; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2014-07-17